NuScale Shares Fall After UBS Downgrade and Pomerantz Investigation
NuScale Power shares were reported lower as UBS downgraded the company to Sell and set a $6 price target, citing competitive erosion, project execution concerns and weak customer commitments. Pomerantz LLP launched an investigation into potential securities fraud involving NuScale. Reports also highlighted the company’s cash-burn concerns and weak financial results, including Q2 2026 revenue of $75,000 and a net loss of $47.54M.
Why it matters
The UBS downgrade places a lower published valuation on NuScale and challenges the company’s competitive and execution outlook. The Pomerantz investigation adds legal uncertainty that could weigh on sentiment, while projected cash needs may increase financing and dilution concerns.
Key facts
- 1UBS downgraded NuScale to Sell and reduced its price target to $6 from $10. stockstotrade.com
- 2Pomerantz LLP opened an investigation into potential securities fraud involving NuScale. stockstotrade.com
- 3NuScale reported Q2 2026 revenue of $75,000 and a net loss of $47.54M. timothysykes.com
- 4UBS was reported to project $700M in negative free cash flow from 2026-2028. timothysykes.com
- 5NuScale shares were reported down 7.29% on October 12, 2026. timothysykes.com
Open questions
- The materials report different share declines, including 7.17%, 5.6%, 4.56% and 7.29%, across separate reports and sessions.
- Revenue figures differ between the reported $31.5M figure and Q2 2026 revenue of $75,000, and the materials do not reconcile their reporting periods.
Summary written by AlphAI AI Desk from 4 of 4 sources. Not investment advice. Figures are as stated by the linked sources.